Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from diabetes

Why are Indians suddenly buying more vitamins after starting Ozempic-like weight loss drugs?

Demand for vitamin and nutritional supplements is surging in India. This trend follows the increased availability of semaglutide-based weight-loss and diabetes medicines. Doctors are advising patients on these drugs to take multivitamins and protein supplements. This is to prevent nutritional deficiencies and muscle loss due to reduced food intake. Sales…

The Economic Times

Insurer denies Rs 20 lakh life insurance claim over diabetes non-disclosure; woman fights back and wins; here’s why

A Delhi woman's Rs 20 lakh life insurance claim, denied due to alleged non-disclosure of diabetes and kidney diseases, was upheld by the State Consumer Commission. The insurer failed to provide sufficient proof of deliberate concealment, leading to a ruling in favor of the policyholder.

The Economic Times

Our top-rated berberine supplement could support your metabolic health – here's what to know

The supplement has become increasingly popular for help managing numerous health issues

Evening Standard

From analysis to the latest developments in health,
read the most diverse news in one place.

Stocks in news: ITC, Nykaa, Lenskart, Ola Electric, IndusInd Bank

Markets saw a volatile session with Nifty trading below the 23,800-24,000 resistance zone, though select heavyweight buying limited downside. Several companies like ITC, Nykaa, and IndusInd Bank are in focus due to Q4 results and news developments, including Lenskart's profit decline and Dr. Reddy's new diabetes drug launch.

The Economic Times

Dr Reddy's launches oral semaglutide biosimilar Obeda in India

Dr. Reddy's Laboratories proudly presents Obeda, a groundbreaking oral semaglutide biosimilar for managing Type 2 diabetes in India. This innovative treatment offers patients the ease of a once-daily oral dosage, available in various strengths to effectively enhance glycaemic control. Dr.

The Economic Times

Plantwatch: how goat’s rue inspired super drug for everything from diabetes to obesity

Galegine compound in plant formed blueprint for metformin drug, but without the toxic side-effects

The Guardian - UK

Stem cells have potent potential for diabetes treatment

Humans have around 30 trillion cells in our adult bodies. Amazingly, each of these cells came from a handful of about 100 stem cells in the earliest days of development. The ability of these embryonic stem cells to turn into any cell type makes them pluripotent — something that researchers…

The Conversation

Read news from The Economist, FT, and more,
with one subscription

NHS rollout of artificial pancreas narrows inequality in diabetes care

People from deprived and minority ethnic backgrounds have better access to device than for previous technologies

The Guardian - UK

5 Silent Eye Warning Signs You Should Never Ignore

Most people think eye problems begin with major vision loss. But the truth is far more dangerous. Your eyes often send quiet warning signals long before serious damage begins. A little blur, slight irritation, occasional headaches, or trouble seeing at night may seem harmless at first. Many people blame stress,…

MyLifeXP

US drugs site TrumpRx to list 600 generics as Donald Trump targets lower prices

President Donald Trump is expanding access to affordable medicines. The government website TrumpRx.gov will now list over 600 generic drugs. This includes common treatments for cholesterol and diabetes. The initiative aims to lower prescription drug costs for Americans. Prices will be integrated from various sources. This move seeks to provide…

The Economic Times

A 4-Week Diabetes Miracle? All 10 Patients in a Chicago Trial Achieved Insulin Independence — Could This Cure Be Coming Soon

For millions of Americans living with Type 1 diabetes, every day revolves around insulin shots, glucose monitors, meal planning, and the constant fear of dangerous blood sugar swings. That is why a small but groundbreaking clinical trial in Chicago is creating massive buzz in the medical world. Researchers reported that…

Budget and the Bees

Men’s Silent Killers: 5 Mild Symptoms That Signal Serious Health Problems

Men often brush off small changes in their bodies, assuming stress, age, or lack of sleep explains everything. That mindset can quietly open the door to serious medical conditions that build over time without loud warning bells. Many life-threatening diseases start with symptoms so mild that they feel almost normal.…

Clever Dude

No Candy, No Soda: 4 States Are Banning Sugary Treats for SNAP Users – How This Could Spread Nationwide

Families using SNAP benefits could soon notice major changes at grocery store checkout lines. Several states are now moving to block purchases of soda, candy, and other sugary snacks with Supplemental Nutrition Assistance Program benefits, arguing that taxpayer-funded food assistance should promote healthier eating habits. Indiana, Nebraska, Utah, and West…

Budget and the Bees

From PCOS to PMOS: What the name change to polyendocrine metabolic ovarian syndrome means for women’s health

“Hopeful,” “excited” and “helpful” for the future of women’s health — these are just some of the words expressed by the team that worked together for more than a decade to change the name polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS).

The Conversation

Get all your
news in one place.

100's of premium titles.
One news app.

MarketBeat

Embecta Faces U.S. Reset as CEO Bets on GLP-1, Owen Mumford Diversification

Embecta (NASDAQ:EMBC) President and CEO Devdatt Kurdikar said the company’s recent U.S. business reset reflected a combination of customer-specific share loss, softer market trends and inventory-related factors, while emphasizing that the diabetes device maker is continuing a broader diversification

Medical Daily

Managing Gestational Diabetes Glucose With Friendly Eating Insulin Support and a Practical Gestational Diabetes Diet

Learn how gestational diabetes affects glucose and insulin, why gestational diabetes screening matters, and how a balanced gestational diabetes diet supports a healthy pregnancy.

Saving Advice

4 High-Use Drugs That Will Have Lower Medicare Prices — And 3 Others Facing Negotiations

Millions of seniors are finally seeing relief from some of the highest prescription drug costs in America as Medicare’s new drug price negotiation program begins...

MarketBeat

DexCom Maps G8 Launch, Coverage Expansion and Double-Digit Growth at Investor Day

DexCom (NASDAQ:DXCM) used its 2026 Investor Day to outline a long-range plan centered on new product launches, broader insurance coverage for continuous glucose monitoring, international expansion and margin improvement. President and Chief Executive Officer Jake Leach said the company’s next phase

Get all your
news in one place.

100's of premium titles.
One news app.

The Economic Times

Dr Reddy’s launches generic Semaglutide injection, popular weight-loss drug, in Canada

Dr Reddy's Laboratories has launched its generic Semaglutide injection in Canada. This marks a significant step for the company in providing treatment for type 2 diabetes. Canada is the first G7 nation to approve this medication. The launch follows a recent introduction in India. Dr Reddy's aims to expand access…

Budget and the Bees

8 Medications Many Chronic-Condition Patients Still Use Despite Updated Safety Guidance

Managing a chronic illness often means taking medication for years, sometimes even decades. While many prescriptions remain highly effective and necessary, updated safety guidance has caused doctors and pharmacists to rethink how certain drugs should be used long term. Millions of patients still rely on these medications because they control…

Latin Times

$5 Trillion Crisis: New Study Warns Diabetes Will Devastate Global Economy by 2050

A study warns diabetes may cost the global economy over $5 trillion by 2050, highlighting its impact on productivity and growth across 190 countries.

International Business Times UK

$5 Trillion Crisis: New Study Warns Diabetes Will Devastate Global Economy by 2050

A study warns diabetes may cost the global economy over $5 trillion by 2050, highlighting its impact on productivity and growth across 190 countries.

Budget and the Bees

A New Study Warns That Women’s Blood Pressure Will Explode by 2050

Women’s heart health is facing a troubling future, according to a new scientific statement from the American Heart Association. Researchers now predict that nearly 60% of women in the United States could develop high blood pressure by 2050 if current trends continue. That sharp increase is raising alarms because high…

MarketBeat

Novo Nordisk A/S Q1 Earnings Call Highlights

Novo Nordisk A/S (NYSE:NVO) said its first quarter of 2026 was marked by rapid uptake of its newly launched Wegovy pill in the U.S., continued expansion of its obesity franchise and a series of pipeline and regulatory milestones, even as adjusted sales declined because of lower realized prices. Chi

MarketBeat

SAB Biotherapeutics Q1 Earnings Call Highlights

SAB Biotherapeutics (NASDAQ:SABS) said its lead type 1 diabetes candidate, SAB-142, remains on track in a registrational Phase 2b trial, as the clinical-stage biopharmaceutical company reported a wider first-quarter loss alongside higher research and development spending. Chief Executive Officer Sa

1 … 3 4 5 6

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the American Heart Association

76 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.